Drug Shortage Report for KADIAN
Report ID | 248177 |
Drug Identification Number | 02184435 |
Brand name | KADIAN |
Common or Proper name | MORPHINE SULFATE |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | MORPHINE SULFATE |
Strength(s) | 20MG |
Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2025-01-21 |
Actual start date | 2025-01-21 |
Estimated end date | 2025-01-22 |
Actual end date | 2025-01-22 |
Shortage status | Resolved |
Updated date | 2025-01-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2025-01-28 | French | Compare |
v4 | 2025-01-28 | English | Compare |
v3 | 2025-01-22 | English | Compare |
v2 | 2025-01-21 | French | Compare |
v1 | 2025-01-21 | English | Compare |
Showing 1 to 5 of 5